GALNS gene expression profiling in Morquio A patients' fibroblasts

Clinica Chimica Acta

Volumn 397, Issue 1-2, 2008, Pages 72-76

  Carraresi, L ^a   Parini, R ^b   Filoni, C ^a   Caciotti, A ^a   Sersale, G ^b   Tomatsu, S ^c   Orlando, C ^d   Zammarchi, E ^d   Guerrini, R ^a   Donati, M A ^a   Morrone, A ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

GALNS expression profiling; GenBank Accession number, D17629; HUGO approved gene symbol, GALNS; Morquio A; Mucopolysaccharidosis IVA (MPS IVA, Morquio type A) OMIM disorder gene accession number, 253000; N acetylgalactosamine 6 sulfate sulfatase E.C. number 3.1.6.4; Real time RT PCR

Indexed keywords

MESSENGER RNA;

ARTICLE; FEMALE; FIBROBLAST; GALNS GENE; GENE; GENE EXPRESSION PROFILING; GENE MUTATION; HUMAN; HUMAN CELL; MALE; MOLECULAR STABILITY; MORQUIO SYNDROME; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING;

ALLELES; CHILD; CHONDROITINSULFATASES; CODON, NONSENSE; EXONS; FEMALE; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; MALE; MUCOPOLYSACCHARIDOSIS IV; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

IVA;

EID: 51249096742     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.07.021     Document Type: Article

References (39)

1. Matalon R., Arbogast B., Justice P., Brandt I.K., and Dorfman A. Morquio's syndrome: deficiency of a chondroitin sulfate N-acetylhexosamine sulfate sulfatase. Biochem Biophys Res Commun 61 (1974) 759-765
2. Singh J., Di Ferrante N., Niebes P., and Tavella D. N-acetylgalactosamine-6-sulfate sulfatase in man. Absence of the enzyme in Morquio disease. J Clin Invest 57 (1976) 1036-1040
3. Morquio L. Sur une forme de dystrophie osseuse familiale. Bull Soc Pediatr (Paris) 27 (1929) 145-152
4. Maroteaux P., and Lamy M. Studying the mucopolysaccharidoses. Lancet II (1967) 510
5. Nelson J., and Thomas P.S. Clinical findings in 12 patients with MPS IVA (Morquio's disease). Clin Genet 33 (1988) 126-130
6. Montaño A.M., Tomatsu S., Gottesman G.S., Smith M., and Orii T. International Morquio A Registry: clinical manifestation and natural course of Morquio A disease. J Inherit Metab Dis 30 (2007) 165-174
7. Tomatsu S., Fukuda S., Masue M., et al. Mucopolysaccharidosis IVA: characterization and chromosomal localization of N-acetylgalactosamine-6-sulfate sulfatase gene and genetic heterogeneity. Am J Hum Genet (Suppl) 51 (1992) A178
8. Baker E., Guo X.H., Orsborn A.M., et al. The Morquio A syndrome (mucopolysaccharidosis IVA) gene maps to 16q24.3. Am J Hum Genet 52 (1993) 96-98
9. Masuno M., Tomatsu S., Nakashima Y., et al. Mucopolysaccharidosis IVA: assignment of the human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene to the chromosome 16q24. Genomics 16 (1993) 777-778
10. Nakashima Y., Tomatsu S., Hori T., et al. Mucopolysaccharidosis IVA: molecular cloning of the human N-acetylgalactosamine-6-sulfate sulfatase gene (GALNS) and analysis of the 5′-flanking region. Genomics 20 (1994) 99-104
11. Tomatsu S., Filocamo M., Orii K.O., et al. Mucopolysaccharidosis IVA (Morquio A): identification of novel common mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene in Italian patients. Hum Mutat 24 (2004) 187-188
12. Maquat L.E. Nonsense-mediated mRNA decay in mammals. J Cell Sci 118 Pt 9 (2005) 1773-1776
13. van Diggelen O.P., Zhao H., Kleijer W.J., et al. A fluorimetric enzyme assay for the diagnosis of Morquio disease type A (MPS IVA). Clin Chim Acta 187 (1990) 131-139
14. den Dunnen J.T., and Antonarakis S.E. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15 (2000) 7-12
15. den Dunnen J.T., and Paalman M.H. Standardizing mutation nomenclature: why bother?. Hum Mutat 22 (2003) 181-182
16. Asselta R., Duga S., Spena S., et al. Congenital afibrinogenemia: mutations leading to premature termination codons in fibrinogen A alpha-chain gene are not associated with the decay of the mutant mRNAs. Blood 98 (2001) 3685-3692
17. Buzina A., and Shulman M.J. Infrequent translation of a nonsense codon is sufficient to decrease mRNA level. Mol Biol Cell 10 (1999) 515-524
18. Denecke J., Kranz C., Kemming D., Koch H.G., and Marquardt T. An activated 5′ cryptic splice site in the human ALG3 gene generates a premature termination codon insensitive to nonsense-mediated mRNA decay in a new case of congenital disorder of glycosylation type Id (CDG-Id). Hum Mutat 23 (2004) 477-486
19. Perrin-Vidoz L., Sinilnikova O.M., Stoppa-Lyonnet D., Lenoir G.M., and Mazoyer S. The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons. Hum Mol Genet 11 (2002) 2805-2814
20. Zhang J., and Maquat L.E. Evidence that translation reinitiation abrogates nonsense-mediated mRNA decay in mammalian cells. EMBO J 16 (1997) 826-833
21. Solis A.S., Shariat N., and Patton. Splicing fidelity, enhancers, and disease. JG Front Biosci 13 (2008) 1926-1942
22. Dölken G. Detection of minimal residual disease. Adv Cancer Res 82 (2001) 133-185
23. Jaeger U., and Kainz B. Monitoring minimal residual disease in AML: the right time for real time. Ann Hematol 82 (2003) 139-147
24. van der Velden V., Hochhaus A., Cazzaniga G., Szczepanski T., Gabert J., and van Dongen J.J. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia 17 (2003) 1013-1034
25. Potratz A., Huttler S., Bierfreund U., Proia R.L., Suzuki K., and Sandhoff K. Quantification of m-RNAs encoding proteins of the glycosphingolipid catabolism in mouse models of GM2 gangliosidoses and sphingolipid activator protein precursor (prosaposin) deficiency. Biochim Biophys Acta 502 (2000) 391-397
26. Rice J.E., Sanchez J.A., Pierce K.E., and Wangh L.J. Real-time PCR with molecular beacons provides a highly accurate assay for detection of Tay-Sachs alleles in single cells. Prenat Diagn 22 (2002) 1130-1134
27. Hermans M.M., van Leenen D., Kroos M.A., et al. Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type II. Hum Mutat 23 (2004) 47-56
28. Dhami R., Passini M.A., and Schuchman E.H. Identification of novel biomarkers for Niemann-Pick disease using gene expression analysis of acid sphingomyelinase knockout mice. Mol Ther 13 (2006) 556-564
29. Lualdi S., Pittis M.G., Regis S., et al. Multiple cryptic splice sites can be activated by IDS point mutations generating misspliced transcripts. J Mol Med 84 (2006) 692-700
30. Lualdi S., Di Rocco M., Corsolini F., et al. Identification of nine new IDS alleles in mucopolysaccharidosis II. Quantitative evaluation by real-time RT-PCR of mRNAs sensitive to nonsense-mediated and nonstop decay mechanisms. Biochim Biophys Acta 1762 (2006) 478-484
31. Montfort M., Chabás A., Vilageliu L., and Grinberg D. Analysis of nonsense-mediated mRNA decay in mutant alleles identified in Spanish Gaucher disease patients. Blood Cells Mol Dis 36 (2006) 46-52
32. Raja M., Azzoni A., Giona F., et al. Movement and mood disorder in two brothers with Gaucher disease. Clin Genet 72 (2007) 357-361
33. Caciotti A., Donati M.A., Procopio E., et al. GM1 gangliosidosis: molecular analysis of 9 patients and development of an RT-PCR assay for GLB1 gene expression profiling. Hum Mut 28 (2007) 204-214
34. Romão L., Inácio A., Santos S., et al. Nonsense mutations in the human beta-globin gene lead to unexpected levels of cytoplasmic mRNA accumulation. Blood 96 (2000) 2895-2901
35. Wang J., Gudikote J.P., Olivas O.R., and Wilkinson M.F. Boundary-independent polar nonsense-mediated decay. EMBO Rep 3 (2002) 274-279
36. Laradi S., Tukel T., Khediri S., et al. Mucopolysaccharidosis type IV: N-acetylgalactosamine-6-sulfatase mutations in Tunisian patients. Mol Genet Metab 87 (2006) 213-218
37. Danckwardt S., Neu-Yilik G., Thermann R., Frede U., Hentze M.W., and Kulozik A.E. Abnormally spliced beta-globin mRNAs: a single point mutation generates transcripts sensitive and insensitive to nonsense-mediated mRNA decay. Blood 99 (2002) 1811-1816
38. Brooks D.A., Muller V.J., and Hopwood J.J. Stop-codon read-through for patients affected by a lysosomal storage disorder. Trends Mol Med 12 (2006) 367-373
39. Kuzmiak H.A., and Maquat L.E. Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges. Trends Mol Med 12 (2006) 306-316